The Ohio State University Comprehensive Cancer Center James Hospital Amp Solove Research Institute News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from The ohio state university comprehensive cancer center james hospital amp solove research institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In The Ohio State University Comprehensive Cancer Center James Hospital Amp Solove Research Institute Today - Breaking & Trending Today

Dr Singh on Treating Lung Cancer CNS Metastasis Management Strategies

Raj Singh, MD, discusses treating patients with lung cancer with CNS metastases. ....

Raj Singh , Paul Brown , Cancer Center , Ohio State University , Radiation Oncology , Comprehensive Cancer Center , Mayo Clinic , The Ohio State University Comprehensive Cancer Center James Hospital Amp Solove Research Institute , Osuccc James , Lung Cancer , Onclive Tv ,

Dr Bezerra on the Real-World Efficacy of Brexu-Cel in B-ALL

Evandro D. Bezerra, MD, discusses real-world outcomes associated with brexucabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
....

Evandrod Bezerra , Ohio State University Comprehensive Cancer Center , International Blood , Marrow Transplant Research Registry , Marrow Transplant Research , The Ohio State University Comprehensive Cancer Center James Hospital Amp Solove Research Institute , Osucc James , Onclive Tv , Brexucabtagene Autoleucel , Brexu Cel , Hematologic Oncology , B Cell Acute Lymphoblastic Leukemia ,

Dr Singer on the Safety of Perioperative Nivolumab and Cabozantinib in RCC

Eric A. Singer, MD, discusses the safety of perioperative nivolumab and cabozantinib in patients with metastatic clear cell renal cell carcinoma.
....

United States , Division Of Urologic Oncology , American Urological Association Annual Meeting , Ohio State University Comprehensive Cancer Center , Ohio State University Wexner Medical Center , Urologic Oncology , Urological Association Annual Meeting , The Ohio State University Comprehensive Cancer Center James Hospital Amp Solove Research Institute , Usuccc James , Genitourinary Cancers , Onclive Tv ,

Dr Malalur on Addressing Unmet Needs in Pancreatic Cancer

Pannaga G. Malalur, MBBS, discusses several unmet needs within pancreatic cancer, including the implementation of updated germline genetic testing guidelines, increased screening of high-risk patients, and improved sequencing of available therapeutics. ....

Pannagag Malalur , National Comprehensive Cancer Network , James Cancer Hospital Solove Research Institute , Ohio State University Comprehensive Cancer Center , Gastrointestinal Cancers , Cancer Hospital , Solove Research Institute , Cancers Symposium , Osuccc James , The Ohio State University Comprehensive Cancer Center James Hospital Amp Solove Research Institute , Gastrointestinal Cancer , Onclive Tv , Pancreatic Ductal Adenocarcinoma , Germline Genetic Testing , Nccn Guidelines , Screening Tools , Next Generation Sequencing ,

Dr Malalur on the Implications of NALIRIFOX in Pancreatic Ductal Adenocarcinoma

Pannaga G. Malalur, MBBS, discusses the implications of the findings for the use of liposomal irinotecan plus 5-fluorouracil, leucovorin, and oxaliplatin in the frontline setting for patients with metastatic pancreatic ductal adenocarcinoma. ....

Pannagag Malalur , James Cancer Hospital Solove Research Institute , Ohio State University Comprehensive Cancer Center , Gastrointestinal Cancers , Cancer Hospital , Solove Research Institute , Cancers Symposium , Osuccc James , The Ohio State University Comprehensive Cancer Center James Hospital Amp Solove Research Institute , Gastrointestinal Cancer , Onclive Tv , Liposomal Irinotecan , Pancreatic Ductal Adenocarcinoma ,